These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Development of a three-factor neuropsychological approach for detecting minimal hepatic encephalopathy. Stewart CA; Enders FT; Schneider N; Felmlee-Devine D; Kamath PS; Smith GE Liver Int; 2010 Jul; 30(6):841-9. PubMed ID: 20412441 [TBL] [Abstract][Full Text] [Related]
6. Mammillary body alterations and spatial memory impairment in Wistar rats with thioacetamide-induced cirrhosis. Méndez M; Méndez-López M; Lopez L; Aller MA; Arias J; Arias JL Brain Res; 2008 Oct; 1233():185-95. PubMed ID: 18703028 [TBL] [Abstract][Full Text] [Related]
7. p38 MAP kinase is a therapeutic target for hepatic encephalopathy in rats with portacaval shunts. Agusti A; Cauli O; Rodrigo R; Llansola M; Hernández-Rabaza V; Felipo V Gut; 2011 Nov; 60(11):1572-9. PubMed ID: 21636647 [TBL] [Abstract][Full Text] [Related]
8. Kynurenic acid synthesis in cerebral cortical slices of rats with progressing symptoms of thioacetamide-induced hepatic encephalopathy. Saran T; Hilgier W; Urbańska EM; Turski WA; Albrecht J J Neurosci Res; 2004 Feb; 75(3):436-40. PubMed ID: 14743457 [TBL] [Abstract][Full Text] [Related]
9. Evidence against a role for endotoxin in the hepatic encephalopathy of rats with thioacetamide-induced fulminant hepatic failure. Chen CT; Chu CJ; Wang TF; Lu RH; Lee FY; Chang FY; Lin HC; Chan CC; Wang SS; Huang HC; Lee SD J Gastroenterol Hepatol; 2005 Mar; 20(3):450-5. PubMed ID: 15740491 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of cognitive alterations in hyperammonemia and hepatic encephalopathy: therapeutical implications. Monfort P; Cauli O; Montoliu C; Rodrigo R; Llansola M; Piedrafita B; El Mlili N; Boix J; Agustí A; Felipo V Neurochem Int; 2009; 55(1-3):106-12. PubMed ID: 19428813 [TBL] [Abstract][Full Text] [Related]
11. Reversal learning impairment and alterations in the prefrontal cortex and the hippocampus in a model of portosystemic hepatic encephalopathy. Méndez M; Méndez-López M; López L; Begega A; Aller MA; Arias J; Arias JL Acta Neurol Belg; 2010 Sep; 110(3):246-54. PubMed ID: 21114133 [TBL] [Abstract][Full Text] [Related]
12. Effects of a high protein diet on cognition and brain metabolism in cirrhotic rats. Méndez-López M; Méndez M; Arias J; Arias JL Physiol Behav; 2015 Oct; 149():220-8. PubMed ID: 26048304 [TBL] [Abstract][Full Text] [Related]
13. Basal and learning task-related brain oxidative metabolism in cirrhotic rats. Méndez M; Méndez-López M; López L; Aller MA; Arias J; Arias JL Brain Res Bull; 2009 Mar; 78(4-5):195-201. PubMed ID: 19015011 [TBL] [Abstract][Full Text] [Related]
14. Reversal of behavioral changes in rats subjected to portacaval shunt with oral neomycin therapy. Conjeevaram HS; Nagle A; Katz A; Kaminsky-Russ K; McCullough AJ; Mullen KD Hepatology; 1994 May; 19(5):1245-50. PubMed ID: 8175148 [TBL] [Abstract][Full Text] [Related]
15. Low grade cirrhosis induces cognitive impairment and motor dysfunction in rats: could be a model for minimal hepatic encephalopathy. Singh S; Trigun SK Neurosci Lett; 2014 Jan; 559():136-40. PubMed ID: 24334168 [TBL] [Abstract][Full Text] [Related]
16. Acetylcholinesterase activity in an experimental rat model of Type C hepatic encephalopathy. Méndez M; Méndez-López M; López L; Aller MA; Arias J; Arias JL Acta Histochem; 2011 May; 113(3):358-62. PubMed ID: 20138653 [TBL] [Abstract][Full Text] [Related]
17. Cerebral oedema is not responsible for motor or cognitive deficits in rats with hepatic encephalopathy. Cauli O; Llansola M; Agustí A; Rodrigo R; Hernández-Rabaza V; Rodrigues TB; López-Larrubia P; Cerdán S; Felipo V Liver Int; 2014 Mar; 34(3):379-87. PubMed ID: 23869990 [TBL] [Abstract][Full Text] [Related]
18. Progressive reduction of sleep time and quality in rats with hepatic encephalopathy caused by portacaval shunts. Llansola M; Cantero JL; Hita-Yañez E; Mirones-Maldonado MJ; Piedrafita B; Ahabrach H; Errami M; Agusti A; Felipo V Neuroscience; 2012 Jan; 201():199-208. PubMed ID: 22108612 [TBL] [Abstract][Full Text] [Related]
19. Portosystemic hepatic encephalopathy model shows reversal learning impairment and dysfunction of neural activity in the prefrontal cortex and regions involved in motivated behavior. Méndez M; Méndez-López M; López L; Aller MA; Arias J; Arias JL J Clin Neurosci; 2011 May; 18(5):690-4. PubMed ID: 21371891 [TBL] [Abstract][Full Text] [Related]